Literature DB >> 17876059

Beta-TrCP1-mediated degradation of PERIOD2 is essential for circadian dynamics.

Silke Reischl1, Katja Vanselow, Pål O Westermark, Nadine Thierfelder, Bert Maier, Hanspeter Herzel, Achim Kramer.   

Abstract

Regulated degradation of circadian clock proteins is a crucial step for rhythm generation per se but also for establishing a normal circadian period. Here, the authors show that the F-box protein beta-transducin repeat containing protein 1 (beta-TrCP1) as part of the E3 ubiquitin ligase complex is an essential component of the mammalian circadian oscillator. Down-regulation of endogenous beta-TrCP1 as well as expression of a dominant-negative form both result in lengthening of the circadian period in oscillating fibroblasts. These phenotypes are due to an impaired degradation of PERIOD (PER) proteins, since expression of beta-TrCP interaction-deficient PER2 variants--but not wild-type PER2--results in a dramatic stabilization of PER2 protein as well as in the disruption of circadian rhythmicity. Mathematical modeling conceptualizes the authors' findings and suggests that loss of sustained rhythmicity in cells with eliminated beta-TrCP-mediated PER2 degradation is due to excessive nuclear repression, a prediction they verified experimentally.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876059     DOI: 10.1177/0748730407303926

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  77 in total

1.  E3 ligases Arf-bp1 and Pam mediate lithium-stimulated degradation of the circadian heme receptor Rev-erb alpha.

Authors:  Lei Yin; Shree Joshi; Nan Wu; Xin Tong; Mitchell A Lazar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 2.  Circadian mRNA expression: insights from modeling and transcriptomics.

Authors:  Sarah Lück; Pål O Westermark
Journal:  Cell Mol Life Sci       Date:  2015-10-26       Impact factor: 9.261

3.  A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta.

Authors:  Tsuyoshi Hirota; Warren G Lewis; Andrew C Liu; Jae Wook Lee; Peter G Schultz; Steve A Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

4.  A large-scale functional RNAi screen reveals a role for CK2 in the mammalian circadian clock.

Authors:  Bert Maier; Sabrina Wendt; Jens T Vanselow; Thomas Wallach; Silke Reischl; Stefanie Oehmke; Andreas Schlosser; Achim Kramer
Journal:  Genes Dev       Date:  2009-03-15       Impact factor: 11.361

Review 5.  Diversity of human clock genotypes and consequences.

Authors:  Luoying Zhang; Louis J Ptáček; Ying-Hui Fu
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

6.  Abnormal retinal development in the Btrc null mouse.

Authors:  Mark Baguma-Nibasheka; Boris Kablar
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

7.  Early doors (Edo) mutant mouse reveals the importance of period 2 (PER2) PAS domain structure for circadian pacemaking.

Authors:  Stefania Militi; Elizabeth S Maywood; Colby R Sandate; Johanna E Chesham; Alun R Barnard; Michael J Parsons; Jennifer L Vibert; Greg M Joynson; Carrie L Partch; Michael H Hastings; Patrick M Nolan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

Review 8.  New insights into non-transcriptional regulation of mammalian core clock proteins.

Authors:  Priya Crosby; Carrie L Partch
Journal:  J Cell Sci       Date:  2020-09-15       Impact factor: 5.285

9.  High-throughput screening and chemical biology: new approaches for understanding circadian clock mechanisms.

Authors:  Tsuyoshi Hirota; Steve A Kay
Journal:  Chem Biol       Date:  2009-09-25

10.  Molecular characterization of Mybbp1a as a co-repressor on the Period2 promoter.

Authors:  Yasuhiro Hara; Yoshiaki Onishi; Katsutaka Oishi; Koyomi Miyazaki; Akiyoshi Fukamizu; Norio Ishida
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.